Sie sind auf Seite 1von 3

COMPARISON OF SHAKLEE'S VITA-LEA & LEADING PRE-NATAL VITAMINS

DR. CHRIS JENSEN, Vice President, Scientific Affairs, Shaklee


On the subject of dietary supplements during pregnancy and lactation, I want to clarify that Vita-ea
can and is used by thousands of consumers as a prenatal supplement! Often people are under the
mistaken impression that pregnancy or lactation re"uires a completely different multi#itamin and
mineral supplement! In point of fact, this isn$t the case! %utritional needs are increased during
pregnancy and lactation, but the #alue of a balanced and comprehensi#e nutritional supplement like
Vita-ea is that it complements an indi#idual$s food intake to help ensure that all nutrient needs are
met! Also, for those women whose physicians recommend additional iron beyond the &' mg pro#ided
in a two table ser#ing of Vita-ea, our Iron plus Vitamin ( formulation is an e)cellent product to
consider!
Some points to keep in mind with regard to Shaklee nutritional supplements during pregnancy and
lactation are as follows*
Vita-ea ser#es as an e)cellent prenatal supplement!
It$s especially important to get sufficient amounts of the + #itamin folic acid e#en before you get
pregnant, to help reduce the risk of your baby ha#ing a common type of birth defect! ,olic acid is
found in Vita-ea and +-(omple)!
(alcium needs increase during pregnancy and lactation! -he ./A during pregnancy and lactation is
&011 mg daily, and any of our four calcium supplements ser#e as e)cellent supplementary sources!
.emember also that a ser#ing of a dairy product, like milk or yogurt, pro#ides about 011-211 mg of
calcium!
Some women re"uire supplementary iron during pregnancy! A blood test by your doctor can determine
if this applies to you! Shaklee Iron plus Vitamin ( ser#es as an e)cellent source of additional iron for
those in need!
Protein needs during pregnancy increase only slightly, and most Americans get plenty of protein!
-herefore, supplementary protein is usually not re"uired! 3owe#er, most Americans could benefit
from healthier sources of protein! Shaklee 4nergi5ing Soy Protein can be used as a high "uality, low-
fat, cholesterol-free alternati#e to traditional high-fat, high-cholesterol protein sources! ,or e)ample,
many people enjoy 4nergi5ing Soy Protein in the morning as a part of breakfast in place of the more
traditional protein sources such as eggs and bacon!
A diet rich in #itamin ( helps promote absorption of iron! Vitamin ( with each meal makes good
sense! As indicated by the information abo#e, a basic supplementation regimen is fine during
pregnancy and lactation! On the other hand, as a general rule, use of medicinal herbs, o#er-the-counter
6O-(7 medications, and prescription medicines is not recommended during pregnancy and lactation
unless you ha#e first cleared this with your physician! Small amounts of other herbs like garlic and
alfalfa should not pose a problem!
,inally, Optiflora is a safe product that you can feel confident in recommending! As for young
children, they can take Optiflora if they can safely consume the capsule! 8e hope this is helpful!
(hris 9ensen, P3/ - Vice President, Scientific Affairs, Shaklee
COMPARISON OF PRENATAL VITAMINS
SHAKLEES VITA-LEA
--(O%-AI%S A 4SS4%-IA &0 VI-A:I%S A%/ ; :I%4.AS I% P.OP4. +AA%(4
--(O%-AI%S 0; 83O4 V4<4-A+4 SO=.(4S 83I(3 A.4 .4A/I4> A+SO.+4/ +> -34 +O/>
--(1%-AI%S %O -O?I( (34:I(AS@
--%O 34.+I(I/4S@
--%O P4S-I(I/4S@
--%O S=<A.@
--%O A.-I,I(IA (OO.S, ,AVO.S O. A//I-IV4S O, A%> AI%/@
--(O%-AI%S P3>O(34:I(AS B -34 AIV4 4%C>:4S %O- ,O=%/ I% S>%-34-I( VI-A:I%S
--P.O(4SS4/ +> O8-34A- :4-3O/ A44PI%< 4%C>:4S AIV4@
--(O%-AI%S &11DE O, ./A O, +IO-I%!
ZENATE (SOLVARY PHARMACEUTICALS)
--(O%-AI%S (A.%A=+A 8A? 834% 34A-4/ -O /4(O:POSI-IO% A%/ 4:I-S A(.I/ S:OA4 A%/
I..I-A-I%< ,=:4S!
--(O%-AI%S :A<%4SI=: S-4A.A-4 834% 34A-4/7 (A=S4S -O?I( ,=:4S!
--(O%-AI%S PO>4-3>4%4 <>(O! 83I(3 :A> P.O/=(4 +.AI% A%/ AI/%4> /A:A<4
--(O%-AI%S S-4A.I( A(I/ 83I(3 :A> (A=S4 I%-4S-I%A O+S-.=(-IO%!
--SAI% S4%SI-ICA-IO% IS =S=A!
--(O%-AI%S -I-A%I=: /IO?I/4 83I(3 :A> (A=S4 P=:O%A.> I..I-A-IO%!
--%O +IO-I%!
--%O PA%-O-34%I( A(I/!
--O8 :A<%4SI=:!
--%O (OPP4.
--%O P3OSP3O.=S
PRECARE CAPLETS (NORTHAMPTON MEDICAL)
--(O%-AI%S %O VI-A:I% A
--%O VI-A:I% +&
--%O VI-A:I% +&0!
--%O +IO-I%!
--/=4 -O I:P.OP4. +AA%(4 O, + VI-A:I%S -3IS (A=S4S A /=:PI%< -3=S %O- =-IICI%< -34
P.OP4. A+SO.P-IO% O, VI-A:I%S +F A%/ ,OI( A(I/!
--%O P3OSP3O.=S!
--%O IO/I%4!
--%O PA%-O-34%I( A(I/!
NATALINS TALETS (MEAD JOHNSON)
--(O%-AI%S %O +IO-I%!
--O8 (A(I=:!
--18 :A<%4SI=:!
--%O P3OSP3O.=S!
--%O PA%-O-34%I( A(I/!
--(O%-AI%S PO>4-34%4 <>(O 83I(3 :A> P.O/=(4 +.AI% A%/ AI/%4>/A:A<4
NIFERE! PN (CENTRAL PHARMACEUTICALS)
--(O%-AI%S %O VI-A:I% 4!
--%O :A<%4SI=:!
--V4.> O8 (A(I=: 4V4S!
--%O P3OSP3O.=S!
--%O +IO-I%!
--(O%-AI%S :4-3>(4=OS4 83I(3 :A> (A=S4 I%-4S-I%A O+S-.=(-IO% I, I%S=,,I(I4%-
8A-4. IS -AA4%!
PRENATE "# (OCK)
--(O%-AI%S %O +IO-I%!
--%O PA%-O-34%I( A(I/!
--%O :A<%4SI=:
--V4.> O8 (A(I=: 4V4S
--:A-4.%A -A+4-S 64/4.47
--(O%-AI%S O%> &GD (A(I=:
--O%> FD :A<%4SI=:
--O%> &1D +IO-I%!
--%O P3OSP3O.=S!
--(O%-AI%S :4-3>(4=OS4 83I(3 :A> (A=S4 I%-4S-I%A O+S-.=(-IO%, I, I%S=,,I(I4%-
8A-4. IS -AA4%!
--(O%-AI%S :4-3>PA.A+4% 83I(3 :A> (A=S4 <AS-.I( =PS4-!
--(O%-AI%SSO/I=: A=.> S=,A-4, A ->PI(A (O:PO=%/ ,O=%/ I% A%IO%I( /4-4.<4%-S!
NATALINS R! (MEAD JOHNSON)
--(O%-AI%S %O P3OSP3O.=S!
--%O IO/I%4!
--(O%-AI%S 3>/.O(3O.I/4 83I(3 :A> +4 A /I.4(- P=:O%A.> I..I-A%- A%/ I%,A:4
(O%9=%(-IV4 O, 4>4S!
--(O%-AI%S (>A%O(O+AA:I% 83I(3 :A> (A=S4 S4%SI-IVI-> .4A(-IO%S,
<AS-.OI%-4S-I%A /IS-.4SS, $-3.O:+OSIS A%/ I-(3I%< .AS3!
STUART PRENATAL (STUART)
--(O%-AI%S %O +IO-I%!
--O8 (A(I=:!
--%O :A<%4SI=:!
--%O P3OSP3O.=S!
--%O IO/I%4!
--(O%-AI%S 3>//.O?P.OP> :4-3>(4=OS4 83I(3 :A> (A=S4 I%-4S-I%A O+S-.=(-IO%, I,
I%S=,,I(I4%- 8A-4. IS -AA4%
STUARTNATAL (STUART)
--(O%-AI%S %O +IO-I%
--O8 (A(I=:!
--%O :A<%4SI=:
--%O P3OSP3O.=S!
--%O IO/I%4!
--%O PA%-O-34%I( A(I/!
--(O%-AI%S (>A%O(O+AA%II% 83I(3 :A> (A=S4 S4%SI-IVI-> .4A(-IO%S,
<AS-.OI%-4S-I%A /IS-.4SS, I-(3I%< A%/ .AS3!
REFERENCES
=%IV4.SI-> O, :ISSISSIPPI 4A.%I%< .4SO=.(4 (4%-4.
(I%I(A -O?I(OO<> O, (O::4.(IA P.O/=(-S, H-3 4/I-IO%,<OSS4I%- S:I-3-3O/<4
(34:I(A 4?POS=.4 A%/ 3=:A% 34A-3, (>%-3IA 8ISO%
3A%/+OOA O, POISO%I%<, &0-3 4/I-IO%, .O+4.- 3! /.4IS+A(3 - 8IIA: .O+4.ISO%
POISO%I%<* -O?I(OO<>* S>:P-O:S* -.4A-:4:-S, 9A> A.4%A - .I(3A./ 3!/.48
3ACA./O=S (34:I(A /4SA .4,4.4%(4, 0%/ 4/I-IO%, .I(3A./ 9! 48IS, S.!